Bifidobacterium longum - 3 of 15 probiotic strains of DeNorma

Bifidobacterium longum (B. longum) performs important functions for our body. For example, it helps inhibit the growth of harmful bacteria, reduces the incidence of constipation and prevents the development of diarrhea in children. This bacterium also plays a role in reducing intestinal inflammation, normalizing cholesterol levels and reducing the incidence of certain types of allergic manifestations in children.

According to a 1997 study on rats for "carcinogenesis", B. Longum in combination with oligosaccharides showed anti-carcinogenic and anti-mutagenic properties.

Properties of B. longum bacteria:
- Improve immunity in adults and children.
- Inhibit the growth of pathogenic bacteria with acids and thus prevent the development of intestinal infections.
- Have anti-inflammatory properties in patients with ulcerative colitis and other inflammatory bowel diseases.
- Act as an auxiliary link in the formation of stable immunity of the child, as it completes the baby's body in the first hours of life together with B. Infantis.
- Reduce cholesterol levels. Dietary supplements containing B. longum significantly reduce overall cholesterol levels and have a positive effect on liver and kidney function in patients with hypercholesterolemia.
- Show anti-mutagenic and anti-cancer properties in the intestine. Prevent the appearance and growth of cancer cells.
- Bifidobacteria play an important role in the production of certain groups of vitamins, especially biotin (vitamin B7).
- B. longum is beneficial for patients undergoing dialysis. According to a study, oral administration of B. longum reduces phosphorus levels in patients on dialysis.
- Also, this bacterium reduces the incidence of food allergic reactions in children.
- Reduce the manifestations of hepatic encephalopathy poisoning in people with cirrhosis of the liver.

B. longum is contained in the symbiotic DeNorma.

#DEHolding #DeNorma #Bifidobacteriumlongum